Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lidocaine block of LQT-3 mutant human Na+ channels.

Circulation research - 1 Jul 1996

An R H, Bangalore R, Rosero S Z, Kass R S

Abstract excerpt

In transiently transfected mammalian cells we have identified pharmacological consequences of a naturally occurring deletion mutation, delta KPQ, of the human heart Na+ channel alpha subunit that previously has been linked to one form of the long QT syndrome, an inherited heart disease. Our resul...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line
Share to Electric Conductivity
Share to Gene Deletion

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Long QT Syndrome

Share to Mutation

Share to Sodium Channels

Share to Time Factors

Source

Identifiers

PMID: 8925557
DOI: 10.1161/01.res.79.1.103

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-8925557-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lidocaine block of LQT-3 mutant human Na+ channels.PMID 8925557Read ↗

The human Nav1.5 F1486 deletion associated with long QT syndrome leads to impaired sodium channel inactivation and reduced lidocaine sensitivity.Semantic proximity Read ↗

Mechanism of lidocaine block of late current in long Q-T mutant Na+ channels.Semantic proximity Read ↗

Characterization of human cardiac Na <sup>+</sup> channel mutations in the congenital long QT syndromeSemantic proximity Read ↗

Exploring mutation specific beta blocker pharmacology of the pathogenic late sodium channel current from patient-specific pluripotent stem cell myocytes derived from long QT syndrome mutation carriers.Semantic proximity Read ↗

Complex interactions in a novel SCN5A compound mutation associated with long QT and Brugada syndrome: Implications for Na+ channel blocking pharmacotherapy for de novo conduction disease.Semantic proximity Read ↗

Altered Na+ channels promote pause-induced spontaneous diastolic activity in long QT syndrome type 3 myocytes.Semantic proximity Read ↗

Pharmacogenetics and anti-arrhythmic drug therapy: a theoretical investigation.Semantic proximity Read ↗

Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.Semantic proximity Read ↗

Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.Semantic proximity Read ↗

Multiple mechanisms of Na+ channel--linked long-QT syndrome.Semantic proximity Read ↗

Rate-dependent QT shortening mechanism for the LQT3 deltaKPQ mutant.Semantic proximity Read ↗

Persistent human cardiac Na+ currents in stably transfected mammalian cells: Robust expression and distinct open-channel selectivity among Class 1 antiarrhythmics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.